Dec |
75 |
SMC Advice Issued in December
2007
Bevacizumab
Eculizumab
Esomeprazole
Fondaparinux
Fosamprenavir
Imatinib (MDS/MPD)
Imatinib (combination therapy in PH + ALL)
Imatinib (monotherapy in PH + ALL)
Imatinib (DFSP)
Imatinib (HES) (CEL)
Risedronate
Rivastigmine transdermal patch
Sevelamer
Tiotropium respimat inhaler
Topotecan
Strontium Ranelate Update
Omalizumab Update
TAPG Update
Advice on glitazone use in patients with established cardiac disease
Forthcoming SMC Advice |
Nov |
74 |
SMC Advice Issued in November
2007
Adalimumab
Ciclesonide inhaler
Conjugated estrogen tablets
Dexrazosane
Epoetin delta
Erdosteine
Formoterol inhaler
Rufinamide
TAPG Update
Co-proxamol Update
Clopidogrel Update - STEMI
Combivent inhaler discontinuation
Outpatient Prescribing
Ertapenem Update - surgical prophylaxis, diabetic foot infections
Forthcoming SMC Advice |
Oct |
Issue
73 |
SMC Advice Issued in October
2007
Betaine
Budesonide rectal foam
Ertapenem
Escitalopram
Omalizumab
Sitagliptin
Ziconotide
Forthcoming SMC Advice
Posaconazole Update - prophylaxis |
Aug/Sept |
Issue
72 |
SMC Advice Issued in
August & September 2007
Abatacept
Beclometasone oral
Bortezomib
Capecitabine
Celecoxib
Clopidogrel
Cytarabine liposomal
Idursulfase
Insulin detemir - Innolet device
Levetiracetam (adjunct paeds)
Levetiracetam (adjunct JME)
Levetiracetam (adjunct idiopathic epilepsy)
Levetiracetam (monotherapy newly diagnosed epilepsy)
Natalizumab
Nebivolol
Pioglitazone
Pregabalin
Risperidone
Rotigotine transdermal patch
Sodium oxybate
Tacrolimus
Testosterone transdermal patch
Vinorelbine soft capsules
Rituximab Update
Oral Isotretinoin Update
TAPG Update
Forthcoming SMC Advice |
July |
Issue
71 |
SMC Advice Issued in July 2007
Bemiparin (DVT prevention in orthopaedic surgery)
Bemiparin (DVT treatment)
Bevacizumab
Erlotinib
Exenatide injection
Ibritumomab
Imiquimod 5% cream
Methylphenidate
Montelukast
Rotigotine transdermal patch
Sunitinib
Trastuzumab
Inhaled insuling Update
Forthcoming SMC Advice |
June |
Issue
70 |
Guidance for the use of
clopidogrel in NHS Tayside (supersedes Issue 51) |
June |
Issue
69 |
SMC Advice Issued in June 2007
Budesonide/formoterol turbohaler
Darunivir
Esomeprazole
Formoterol
Posaconazole
Ranibizumab
Testosterone gel
TAPG Update
Methotrexate 10mg tablets Update
Forthcoming SMC Advice |
May |
Issue
68 |
SMC Advice Issued in May 2007
Azelaic acid
Buprenorphine
Dasatinib (CLM)
Dasatinib (ALL)
Desmopressin 240mg
Desmopressin
Dexrazosane
Dibotermin alfa
Docetaxel
Grazax
Infliximab (plaque psoriasis)
Infliximab (ulcerative colitis)
Infliximab (active Crohn's disease)
Infliximab (fistulising Crohn's disease) Lanthanum carbonate
Sitaxentan
Topotecan
TAPG Update
Forthcoming SMC Advice |
March |
Issue
67 |
SMC Advice Issued in March
2007
Alglucosidase alfa
Amlodipine/valsartan
Buprenorphine/naloxone
Clostridium botulinum type A toxin
Glyceryl trinitrate 0.4% rectal ointment
Ivabradine
Lidocaine 5% medicated plaster
Parathyroid hormone
Pioglitazone
Glitazone Update
TAPG Update
Forthcoming SMC Advice
Status of SMC advice in relation to SIGN and NICE |
February |
Issue
66 |
SMC Advice Issued in February
2007
Deferasirox
Donepezil orodispersible
Interferon beta-1b
Pemetrexed
Propiverine
Rimonabant
Sunitinib
Tachosil
Tacrolimus
Urokinase Update
Cinacalcet Update
TAPG Update
Forthcoming SMC Advice |
January |
Issue
65 |
SMC Advice Issued in January
2007
Bulsulfan IV
Clofarabine
Daptomycin 500mg
Dorzolomide/timolol preservative free eye drops
Ertapenem
Omalizumab
Varenicline
Cilostazol Update
Inhaled Insuling Update
Methotrexate sc injection Update
Tacrolimus ointment Update
TAPG Update
Forthcoming SMC Advice |